Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
FDA Statement
Sort By
Newest First
1 / 3
COVID-19 Breathalyzer Diagnostic
Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples
U.S. Food & Drug Administration
PR-M04-22-09
Apr 14, 2022
Regulatory
FDA Makes Low-Risk Determination for Marketing of Products from Genome-Edited Beef Cattle After Safety Review
U.S. Food & Drug Administration
PR-M03-22-03
Mar 07, 2022
FDA
FDA Prepares for Resumption of Domestic Inspections with New Risk Assessment System
U.S. Food & Drug Administration
PR-M07-20-NI-016
Jul 13, 2020
Coronavirus
FDA Issues Statement on Ensuring Safety of Foreign Products During Coronavirus Outbreak
Nice Insight
PR-M02-20-NI-035
Feb 25, 2020
Drug Pricing
FDA CDER Head Castigates Pharma Industry
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M09-19-NI-017
Sep 20, 2019
FDA
Statement Alerting Patients and Health Care Professionals of NDMA Found in Samples of Ranitidine
U.S. Food & Drug Administration
PR-M09-19-NI-043
Sep 18, 2019
FDA Statement
Statement on Agency’s Efforts to Increase Transparency in Medical Device Reporting
Nice Insight
PR-M06-19-NI-048
Jun 26, 2019
FDA
Gluten-Free Food Labeling: Important Information for Those with Celiac Disease
U.S. Food & Drug Administration
PR-M05-19-NI-029
May 09, 2019
FDA Statement
Statement from FDA on New Efforts to Protect Women's Health and Help to Ensure the Safety of Breast Implants
U.S. Food & Drug Administration
PR-M05-19-NI-016
May 06, 2019
FDA Statement
Statement from the FDA's Center for Devices and Radiological Health on Reducing Risks Associated with Surgical Staplers
U.S. Food & Drug Administration
PR-M04-19-NI-074
Apr 24, 2019
FDA Statement
FDA Statement from Deputy Commissioner On New Steps to Protect Consumers from Unlawful Ingredients in Dietary Supplements
U.S. Food & Drug Administration
PR-M04-19-NI-059
Apr 18, 2019
Shortage
FDA Efforts to Mitigate Temporary Shortage of Pediatric Breathing Tubes Due to Recent Closure of Illinois Sterilization Facility
U.S. Food & Drug Administration
PR-M04-19-NI-049
Apr 16, 2019
FDA Statement
FDA Statement on New Opioid Analgesic Labeling Changes
U.S. Food & Drug Administration
PR-M04-19-NI-042
Apr 12, 2019
FDA Warning
FDA Warns About Risks of Using Home Use Test Strips that are Pre-owned or Not Authorized for Sale in U.S., Including Those for Glucose, Warfarin
U.S. Food & Drug Administration
PR-M04-19-NI-038
Apr 11, 2019
FDA
Statement from FDA on the Agency's List of Known Nitrosamine-free Valsartan and ARB Class Medicines
U.S. Food & Drug Administration
PR-M04-19-NI-035
Apr 10, 2019
Stem Cells
Statement by FDA on Efforts to Stop Stem Cell Clinics and Manufacturers from Marketing Unapproved Products and Advance Legitimate Development
U.S. Food & Drug Administration
PR-M04-19-NI-031
Apr 09, 2019
Compounded Drugs
Statement from FDA on New 2019 Efforts to Improve the Quality of Compounded Drugs
U.S. Food & Drug Administration
PR-M04-19-NI-030
Apr 09, 2019
FDA
Statement by FDA on Expanded Patient Access Looking Forward
U.S. Food & Drug Administration
PR-M04-19-NI-009
Apr 03, 2019
FDA
U.S. FDA Commissioner Gottlieb Appears Before the Senate Appropriations Committee
Emilie Branch
Pharma's Almanac
PAO-M04-19-NI-002
Apr 02, 2019
FDA Statement
Statement from FDA Commissioner On Preventing Medical Device shortages and Effective Sterilization Amid Contract Sterilization Facility Shutdown
U.S. Food & Drug Administration
PR-M03-19-NI-084
Mar 29, 2019
1 / 3
